Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medpace Holdings Inc (MEDP)

Medpace Holdings Inc (MEDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,878,446
  • Shares Outstanding, K 28,381
  • Annual Sales, $ 2,530 M
  • Annual Income, $ 451,120 K
  • EBIT $ 563 M
  • EBITDA $ 591 M
  • 60-Month Beta 1.42
  • Price/Sales 5.01
  • Price/Cash Flow 26.24
  • Price/Book 27.39

Options Overview Details

View History
  • Implied Volatility 36.49% (-0.03%)
  • Historical Volatility 58.22%
  • IV Percentile 34%
  • IV Rank 22.11%
  • IV High 70.52% on 04/11/25
  • IV Low 26.83% on 08/15/25
  • Expected Move (DTE 26) 40.90 (9.01%)
  • Put/Call Vol Ratio 0.41
  • Today's Volume 120
  • Volume Avg (30-Day) 259
  • Put/Call OI Ratio 1.29
  • Today's Open Interest 3,633
  • Open Int (30-Day) 2,181
  • Expected Range 412.87 to 494.67

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 3.74
  • Number of Estimates 3
  • High Estimate 3.86
  • Low Estimate 3.60
  • Prior Year 3.67
  • Growth Rate Est. (year over year) +1.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
392.35 +15.65%
on 02/12/26
624.00 -27.28%
on 01/21/26
-148.63 (-24.67%)
since 01/20/26
3-Month
392.35 +15.65%
on 02/12/26
628.92 -27.85%
on 01/16/26
-132.39 (-22.59%)
since 11/20/25
52-Week
250.05 +81.47%
on 04/22/25
628.92 -27.85%
on 01/16/26
+108.92 (+31.58%)
since 02/20/25

Most Recent Stories

More News
Medpace Holdings Under Investigation After Book-to-Bill Miss Exposes Cancellation Surge and Pipeline Fragility

(NASDAQ: MEDP)

MEDP : 453.77 (+1.64%)
Lost Investment in Medpace Holdings, Inc. (MEDP)? Levi & Korsinsky Launches Securities Fraud Investigation

New York, New York--(Newsfile Corp. - February 17, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Medpace Holdings, Inc. ("Medpace Holdings, Inc.") (NASDAQ: MEDP)...

MEDP : 453.77 (+1.64%)
The 5 Most Interesting Analyst Questions From Medpace’s Q4 Earnings Call

The 5 Most Interesting Analyst Questions From Medpace’s Q4 Earnings Call

MEDP : 453.77 (+1.64%)
1 Cash-Producing Stock with Competitive Advantages and 2 That Underwhelm

1 Cash-Producing Stock with Competitive Advantages and 2 That Underwhelm

MEDP : 453.77 (+1.64%)
FIVE : 220.09 (+1.91%)
ELAN : 24.98 (-0.87%)
MEDP Q4 Deep Dive: Cancellations and Metabolic Trial Mix Pressure Margins Despite Strong Growth

MEDP Q4 Deep Dive: Cancellations and Metabolic Trial Mix Pressure Margins Despite Strong Growth

MEDP : 453.77 (+1.64%)
Medpace: Q4 Earnings Snapshot

Medpace: Q4 Earnings Snapshot

MEDP : 453.77 (+1.64%)
Medpace (NASDAQ:MEDP) Reports Bullish Q4 CY2025

Medpace (NASDAQ:MEDP) Reports Bullish Q4 CY2025

MEDP : 453.77 (+1.64%)
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Results

Revenue of $708.5 million in the fourth quarter of 2025 increased 32.0% from revenue of $536.6 million for the comparable prior-year period, representing a backlog conversion rate of 23.6%. ...

MEDP : 453.77 (+1.64%)
Earnings To Watch: Medpace (MEDP) Reports Q4 Results Tomorrow

Earnings To Watch: Medpace (MEDP) Reports Q4 Results Tomorrow

MEDP : 453.77 (+1.64%)
3 Market-Beating Stocks to Consider Right Now

3 Market-Beating Stocks to Consider Right Now

MEDP : 453.77 (+1.64%)
META : 655.66 (+1.69%)
AXON : 433.91 (-1.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

Relative Strength just crossed above 30%. The market has bounced from oversold territory. Beware of a potential mean reversion.

See More Share

Business Summary

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.

See More

Key Turning Points

3rd Resistance Point 472.46
2nd Resistance Point 463.58
1st Resistance Point 458.68
Last Price 453.77
1st Support Level 444.90
2nd Support Level 436.02
3rd Support Level 431.12

See More

52-Week High 628.92
Fibonacci 61.8% 484.19
Last Price 453.77
Fibonacci 50% 439.48
Fibonacci 38.2% 394.78
52-Week Low 250.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar